Nature Biotechnology
15, 653 - 657 (1997)
doi:10.1038/nbt0797-653
Oral vaccination of mice against tetanus with recombinant Lactococcus lactisKaren Robinson1, Lisa M. Chamberlain1, Karin M. Schofield1, Jeremy M. Wells1
& Richard W.F. Le Page1, *
1Division of Microbiology and Parasitology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK.
*e-mail: kr204@mole.bio.cam.ac.uk To determine whether a protective immune response could be elicited by oral delivery of a recombinant bacterial vaccine, tetanus toxin fragment C (TTFC) was expressed constitutively in Lactococcus lactis and administered orally to C57 BL/6 mice. The antibody titers elicited were lower than those following intranasal immunization (a route already known to result in high-level systemic anti-TTFC immune responses) but the protective efficacy was the same order of magnitude. The serum antibody isotypes elicited were predominantly lgG1 and lgG2a. TTFC-specific fecal IgA responses could be detected following oral or intranasal immunization. Chemically killed lactococci administered via the intranasal route were also able to elicit serum antibody responses of similar levels and kinetics to those induced by live bacteria.
REFERENCES
- Wells, J.M. and Schofield, K.M. 1996. pp. 37−62 in Lactic Acid Bacteria: Current Advances in Metabolism, Genetics and Applications. NATO ASI Series vol H98. Bozoglu, T.F. and Ray, B. (eds.) Springer-Verlag, Berlin. | ChemPort |
- Newby, T.J. and Stokes, C.R. 1984. The intestinal immune system and oral vaccination. Vet. Immunol. Immunopathol. 6: 67−105. | ChemPort |
- McGhee, J.M., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M., and Kiyono, H. 1992. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10: 75−88. | Article | PubMed | ISI | ChemPort |
- Gruzza, M., Duval-Iflah, Y., and Ducluzeau, R. 1992. Colonisation of the digestive tract of germfree mice by genetically engineered strains of Lactococcus lactis: study of recombinant DNA stability. Microb. Releases 1: 165−171. | PubMed | ChemPort |
- Wells, J.M., Norton, P.M., and Le Page, R.W.F. 1995. Progress in the development of mucosal vaccines based on Lactococcus lactis. Int. Dairy J. 5: 1071−1079. | Article | ISI | ChemPort |
- Challacombe, S.J., 1983. Salivary antibodies and systemic tolerance in mice after oral immunization with bacterial antigens. Ann. N.Y. Acad. Sci. 409: 177−192. | PubMed | ChemPort |
- Wold, A.E., Dahlgren, U.I.H., Hanson, L.A., Mattsby-Baltzer, I., and Midvetdt, T. 1989. Difference between bacterial and food antigens in mucosal immunogenicity. Infect Immun. 57: 2666−2673. | PubMed | ISI | ChemPort |
- Challacombe, S.J., Rahman, D., JefferyH., Davis, S.S., and O'Hagan, D.T., 1992. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology 76: 164−168. | PubMed | ISI | ChemPort |
- Marteau, P., and Rambaud, J.-C. 1993. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol. Revs. 12: 207−220. | Article | ChemPort |
- Di Tommaso, A., de Magistris, M.T., Bugnoli, M., Rappuoli, R., and Abrignani, S 1994. Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen presentation. Infect. Immun. 62: 1830−1834. | PubMed | ChemPort |
- Cryz, S.J., Furer, E., and Germanier, R. 1982. Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholere. Infect. Immun. 38: 21−26. | PubMed | ISI |
- Eisenberg, G.H.G. and Osterman, J.V. 1977.Experimental scrub typhus immunogens: gamma-irradiated and formalinised rickettsie. Infect. Immun. 15: 124−131. | PubMed | ISI |
- Bachmann, M.F., Kundig, T.M., Kalberer, C.P., Hengartner, H., and Zinkernagel, R.M. 1993. Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-Help- independent B-cell responses. J. Virol. 67: 3917−3922. | PubMed | ISI | ChemPort |
- Tarkkanen, J., Saksela, E., and Lanier, L.L 1986. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell. J. Immunol. 137: 2428−2433. | PubMed | ISI | ChemPort |
- Fairweather, N.F., Lyness, V.A., and Maskell, D.J. 1987. Immunization of mice against tetanus with fragments of tetanus toxin synthesised in Escherichia coli. Infect. Immun. 55: 2541−2545. | PubMed | ISI | ChemPort |
- Wells, J.M., Wilson, P.W., Norton, P.M., Gasson, M.J., and Le Page, R.W.F. 1993. Lactococcus lactis : high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol. Microbiol. 8: 1155−1162. | PubMed | ISI | ChemPort |
- Hohmann, A., Schmidt, G., and Rowley, D. 1979. Intestinal and serum antibody responses in mice after oral immunization with Salmonella, Escherichia coil and Salmonella-Escherichia coli hybrid strains. Infect. Immun. 25: 27−33. | PubMed | ISI | ChemPort |
- VanCott, J.L., Staats, H.F., Pascual, D.W., Roberts, M., Chatfield, S.N., Yamamoto, M., et al. 1996. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J. Immunol. 156: 1504−1514. | PubMed | ISI | ChemPort |
- Chamberlain, L.M., Robinson, K., Wells, J.M., and Le Page, R.W.F 1995. Immunogenicity of glutathione S-transferase (P28) from Schistosoma mansoni expressed in Lactococcus lactis. Immunology 86 (suppl. 1):139.
- Balloul, J.-M., Grzych, J.-M., Pierce, R.J., and Capron, A. A., 1987. Purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis. J. Immunol. 138: 3448−3453. | PubMed | ISI | ChemPort |
- Lagranderie, M., Murray, A., Gicquel, B., Leclerc, C., and Gheorghiu, M. 1993. Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen. Vaccine. 11: 1283−1290. | Article | PubMed | ISI | ChemPort |
- Medaglini, D., Pozzi, G., King, T.P., and Fischetti, V.A. 1995. Mucosal and systemic responses to a recombinant protein expressed on the surface of the oral commensal Streptococcus gordonii after oral colonisation. Proc. Natl. Adac. Sci. USA 92: 6868−6872. | ChemPort |
- Gasson, M.J. 1983. Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast induced curing. J. Bacteriol. 154: 1−9. | PubMed | ISI | ChemPort |
- Wells, J.M., Wilson, P.W., and Le Page, R.W.F. 1993. Improved cloning vectors and transformation procedure for Lactococcus lactis. J. Appl. Bacteriol. 74: 629−636. | PubMed | ISI | ChemPort |
- Norton, P.M., Brown, H.W.G., and Le Page, R.W.F. 1994. The immune response to Lactococcus lactis : Implications for its use as a vaccine delivery vehicle. FEMS Microbiol. Letts. 120: 249−256. | Article | ChemPort |
|
